LACTIGA
Lactiga is an award-winning, venture-backed biotherapeutics company developing novel biologics to treat and prevent infections with a focus on improving the quality of life in patients with Primary Immunodeficiency Diseases. We are unlocking the full therapeutic value of human milk to battle even the world’s most dangerous pathogens.
LACTIGA
Industry:
Biotechnology Pharmaceutical
Founded:
2017-01-01
Address:
Princeton, New Jersey, United States
Country:
United States
Website Url:
http://www.lactiga.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
1.49 M USD
Technology used in webpage:
SPF Euro Google Apps For Business Google Google Cloud Google Cloud Iowa Google DNS Google Domains Google Cloud DNS
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Sonnet BioTherapeutics
Sonnet BioTherapeutics is a biotechnology company for innovating biologic drugs of the single or bispecific mechanism of action.
Current Employees Featured
Founder
Investors List
Unnamed Investor
Unnamed Investor investment in Grant - Lactiga
1517 Fund
1517 Fund investment in Seed Round - Lactiga
Jude Gomila
Jude Gomila investment in Seed Round - Lactiga
Checkmate Capital
Checkmate Capital investment in Seed Round - Lactiga
Unnamed Investor
Unnamed Investor investment in Seed Round - Lactiga
LaunchYU
LaunchYU investment in Grant - Lactiga
National Institutes of Health
National Institutes of Health investment in Grant - Lactiga
Official Site Inspections
http://www.lactiga.com
- Host name: 198.185.159.145
- IP address: 198.185.159.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Lactiga"
Lactiga - Developing novel antibodies for mucosal infections in …
Nov 1, 2021 · Lactigaâ„¢ is an award-winning, venture-backed biotherapeutics company developing novel biologics to treat and prevent infections with a focus on improving the quality …See details»
About - Lactiga
Lactiga, with offices in New Jersey and Toronto , is a biotechnology company focused on developing novel biologics to tackle even the most severe mucosal infections in immunodeficient patients. Our technology targeting mucosal …See details»
Lactiga - Crunchbase Company Profile & Funding
Lactiga is an award-winning, venture-backed biotherapeutics company developing novel biologics to treat and prevent infections with a focus on improving the quality of life in patients with …See details»
Lactiga Announces NIH-Funded Partnership with Mount Sinai to …
Nov 1, 2021 · PRINCETON, N.J.– (BUSINESS WIRE)–Lactiga Inc., a biotechnology company advancing its patented anti-infective biologic, LCTG-001, announced today a collaboration …See details»
Lactiga - LinkedIn
Lactiga is a venture-backed, NIH-funded biotherapeutics company developing patented biologics to treat and prevent infections with a focus on improving the quality of life in patients with...See details»
Lactiga - Company Profile - Innovation Factory
Lactiga is an award-winning, venture-backed biotherapeutics company committed to restoring mucosal immunity in patients with rare immunodeficiency diseases. We are unlocking the full …See details»
Lactiga Company Profile 2024: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for Lactiga. Use the PitchBook Platform to explore the full profile.See details»
Lactiga Announces NIH-Funded Partnership with Mount Sinai to …
Oct 14, 2020 · Biotech firm Lactiga announces $2 million NIH award to advance a novel COVID-19 therapeutic in collaboration with Mount Sinai Hospital in New York.See details»
YSpace Markham Business Venture Lactiga Receives …
Aug 14, 2023 · Lactiga US, Inc., a visionary biotechnology company unlocking the therapeutic value of human milk antibodies, proudly announced today that the US Food and Drug Administration (USFDA) has granted "Rare Pediatric Disease" …See details»
Lactiga - LinkedIn
Lactiga is a venture-backed, NIH-funded biotherapeutics company developing patented biologics to treat and prevent infections with a focus on improving the quality of life in patients with...See details»
Pipeline - Lactiga
We are pioneering the development of novel biologics to prevent and treat infections. By keeping the focus on immunodeficient patients, we are developing therapies to treat unmet medical …See details»
Lactiga Continues to Build a Substantial Global Biologics
Jul 20, 2021 · Lactiga is an award-winning company focused on developing biologic antibodies to treat and prevent mucosal infections in patients with Primary Immunodeficiency Diseases …See details»
Lactiga US, Inc. | Life Sciences PA - Default Site
Lactiga Inc. is a biotechnology company developing new treatment options for patients with Primary Immunodeficiency Diseases including Selective IgA Deficiency, Common Variable …See details»
Lactiga Receives FDA ‘Rare Pediatric Disease’ Designation for ...
Aug 15, 2023 · Lactiga's has received FDA RPD designation for its biologic, LCTG-001, a mucosal antibody replacement therapy for treating CVID in pediatric patients. LCTG-001 on …See details»
Lactiga Therapeutics Raises $1.6M USD in Oversubscribed Pre …
Sep 21, 2022 · NORTH BRUNSWICK, N.J., Sept. 21, 2022 (GLOBE NEWSWIRE) -- Lactiga Therapeutics, an early-stage biotechnology company focused on improving the quality of life of …See details»
Lactiga - Products, Competitors, Financials, Employees, …
Lactiga is a biotherapeutics company that focuses on the development of novel biologics in the healthcare industry. The company's main offerings include the creation of biologics to treat …See details»
Contact - Lactiga
At Lactiga, we’re excited and motivated about our work and our mission. Please get in touch to learn more.See details»
Lactiga - Funding, Financials, Valuation & Investors - Crunchbase
Lactiga is a biotherapeutics company advancing its patented biologics to transform the anti-infective sector and protect vulnerable patientsSee details»
Awards & Announcements - Lactiga
Nov 3, 2020 · Lactiga selected for the RESI Innovator’s Pitch Challenge Lactiga is 1 of 6 Featured startups at the Redefining Early Stage Investments virtual conference from November 17-19th. …See details»
Lactiga - Overview, News & Similar companies | ZoomInfo.com
Aug 14, 2023 · Who is Lactiga. Lactiga is an award-winning, venture-backed biotherapeutics company developing novel biologics to treat and prevent infections with a focus on impr oving …See details»